Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Lymphoma, Chronic Lymphocytic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02258529
What this trial is testing

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

Who this might be right for
Follicular LymphomaSmall Lymphocytic Lymphoma
Gilead Sciences 10
Not applicableNot Yet RecruitingNCT07759661
What this trial is testing

Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Splenic Marginal Zone LymphomaHairy Cell Leukemia (HCL)
IRCCS San Raffaele 64
Not applicableEnded earlyNCT00965861
What this trial is testing

SCRI Tissue Testing Registry

Who this might be right for
MelanomaMyelodysplastic SyndromeMultiple Myeloma+1 more
SCRI Development Innovations, LLC 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03534323
What this trial is testing

Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

Who this might be right for
Chronic Lymphocytic LeukemiaRichter Syndrome
Dana-Farber Cancer Institute 55
Early research (Phase 1)Ended earlyNCT04804254
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers

Who this might be right for
B-cell Lymphoma
AbbVie 5
Testing effectiveness (Phase 2)WithdrawnNCT01754870
What this trial is testing

Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT00004002
What this trial is testing

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT00462605
What this trial is testing

MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+25 more
National Cancer Institute (NCI) 24
Early research (Phase 1)WithdrawnNCT05037669
What this trial is testing

Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma
University of Pennsylvania
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT00882076
What this trial is testing

Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias

Who this might be right for
Leukemia
Milton S. Hershey Medical Center 22
Early research (Phase 1)UnknownNCT01619761
What this trial is testing

NK Cells in Cord Blood Transplantation

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT00004061
What this trial is testing

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

Who this might be right for
LeukemiaLymphomaOral Complications
Memorial Sloan Kettering Cancer Center 111
Early research (Phase 1)Study completedNCT00562380
What this trial is testing

AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

Who this might be right for
LymphomaProstate CancerSarcoma+2 more
Amgen 64
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT02514083
What this trial is testing

A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
National Heart, Lung, and Blood Institute (NHLBI) 29
Testing effectiveness (Phase 2)Study completedNCT01930162
What this trial is testing

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant

Who this might be right for
Single Umbilical Cord Blood TransplantationNon-myeloablative ConditioningAcute Lymphocytic Leukemia+4 more
Novartis Pharmaceuticals 9
Early research (Phase 1)Study completedNCT01650727
What this trial is testing

Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Merck Sharp & Dohme LLC 5
Early research (Phase 1)Study completedNCT00005580
What this trial is testing

Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Virginia Commonwealth University 54
Testing effectiveness (Phase 2)Study completedNCT00438880
What this trial is testing

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Adult Non-Hodgkin LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone Lymphoma+9 more
Mayo Clinic 38
Next Page